Takashi Mori - Mediantechn Director - Representative of Canon Inc
| ALMDT Stock | EUR 3.30 0.04 1.20% |
Director
Mr. Takashi Mori has served as Director Representative of Canon Inc at Median Technologies SA. He is Chief of Canon Inc. Medical Imaging Project within the company Corporationrationrate RD Headquarters. Prior to joining Canon in 2009, he spent 15 years at General Electric Company in Japan in various management positions, including Executive Director, Strategic Growth at GE Healthcare Medical Diagnostic Business, and Executive Vice President Director at Nihon MediPhysics Co., a joint venture between GE and Sumitomo Chemical Co. Ltd
| Professional Marks | MBA |
| Phone | 33 4 93 33 37 77 |
| Web | https://www.mediantechnologies.com |
Mediantechn Management Efficiency
The company has return on total asset (ROA) of (0.2475) % which means that it has lost $0.2475 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of (5.1128) %, meaning that it generated substantial loss on money invested by shareholders. Mediantechn's management efficiency ratios could be used to measure how well Mediantechn manages its routine affairs as well as how well it operates its assets and liabilities.Similar Executives
| Showing other executives | DIRECTOR Age | ||
| Frederique Corallo | OSE Pharma SA | N/A | |
| Maurice Salama | Quantum Genomics SA | N/A | |
| JeanPatrick Demonsang | OSE Pharma SA | N/A | |
| Diane Jorkasky | OSE Pharma SA | 62 | |
| Nicolas Poirier | OSE Pharma SA | 41 | |
| Olivier Madonna | Quantum Genomics SA | N/A | |
| Didier Hoch | OSE Pharma SA | N/A | |
| Christian Bechon | Quantum Genomics SA | 53 | |
| Jean Theron | OSE Pharma SA | N/A | |
| Gilles Pelisson | OSE Pharma SA | 60 | |
| JeanPascal Conduzorgues | OSE Pharma SA | N/A | |
| Fabrice Balavoine | Quantum Genomics SA | N/A | |
| Walter Flamenbaum | OSE Pharma SA | 73 | |
| Sophie Brouard | OSE Pharma SA | N/A | |
| Evelyne Paper | Biosynex | N/A | |
| Marc Karako | Quantum Genomics SA | N/A | |
| Gerard Tobelem | OSE Pharma SA | N/A | |
| David Weese | OSE Pharma SA | 59 | |
| Berangere Vasseur | OSE Pharma SA | N/A | |
| Guy Chatelain | OSE Pharma SA | N/A | |
| Brigitte Dreno | OSE Pharma SA | N/A | |
Management Performance
| Return On Equity | -5.11 | |||
| Return On Asset | -0.25 |
Mediantechn Leadership Team
Elected by the shareholders, the Mediantechn's board of directors comprises two types of representatives: Mediantechn inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Mediantechn. The board's role is to monitor Mediantechn's management team and ensure that shareholders' interests are well served. Mediantechn's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Mediantechn's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Gerard Milhiet, Co-Founder, Executive VP and Director | ||
| Takashi Hayashi, Managing Japan | ||
| Bill Broderick, VP Services | ||
| Jacques Souquet, Director | ||
| Ciaran Cooper, Clinical Devel | ||
| MD MS, Chief Officer | ||
| Kapil Dhingra, Director | ||
| Nicholas Campbell, Chief Commercial Officer | ||
| Jerome Windsor, Vice President - Business Development Pharma | ||
| Otello Stampacchia, Director | ||
| Takashi Mori, Director - Representative of Canon Inc | ||
| Dennis Atkinson, Director - Representative of ePlanet Ventures Ltd | ||
| Fredrik Brag, Co-Founder, Chairman, CEO and Pres | ||
| Timothy Haines, Director | ||
| JeanChristophe Montigny, Chief Officer | ||
| Nohza Boujemaa, Chief Science and Innovation Officer | ||
| Michael Auffret, Head of Regulatory Affair and VP of Product Management and Regulatory | ||
| Marjorie Kooman, VP Relations | ||
| Emmanuelle Leygues, Head Communications | ||
| Franck Lescure, Director - Representative of Auriga Partners | ||
| Arnaud Butzbach, Co-Founder, CTO and VP of Operations | ||
| Oran Muduroglu, Director | ||
| Jeanne Hecht, COO | ||
| Nicolas Dano, Chief Unit | ||
| Souhil Zaim, Member of the Executive Committee, Medical Director | ||
| Sophie Campagno, Chief Services | ||
| Bernard Reymann, CFO |
Mediantechn Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Mediantechn a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | -5.11 | |||
| Return On Asset | -0.25 | |||
| Profit Margin | (0.80) % | |||
| Operating Margin | (0.77) % | |||
| Current Valuation | 117.65 M | |||
| Shares Outstanding | 15.74 M | |||
| Shares Owned By Insiders | 28.90 % | |||
| Shares Owned By Institutions | 18.72 % | |||
| Price To Earning | (13.07) X | |||
| Price To Book | 271.96 X |
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Mediantechn in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Mediantechn's short interest history, or implied volatility extrapolated from Mediantechn options trading.
Pair Trading with Mediantechn
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Mediantechn position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Mediantechn will appreciate offsetting losses from the drop in the long position's value.Moving together with Mediantechn Stock
| 0.72 | ALTHE | Theradiag SA Earnings Call Today | PairCorr |
| 0.64 | GNFT | Genfit | PairCorr |
| 0.61 | ALEUP | Europlasma SA | PairCorr |
The ability to find closely correlated positions to Mediantechn could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Mediantechn when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Mediantechn - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Mediantechn to buy it.
The correlation of Mediantechn is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Mediantechn moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Mediantechn moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Mediantechn can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Mediantechn. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in estimate. You can also try the Headlines Timeline module to stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity.
Complementary Tools for Mediantechn Stock analysis
When running Mediantechn's price analysis, check to measure Mediantechn's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Mediantechn is operating at the current time. Most of Mediantechn's value examination focuses on studying past and present price action to predict the probability of Mediantechn's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Mediantechn's price. Additionally, you may evaluate how the addition of Mediantechn to your portfolios can decrease your overall portfolio volatility.
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
| Share Portfolio Track or share privately all of your investments from the convenience of any device | |
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
| Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
| Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
| Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators | |
| Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals |